Engineering CAR T Cells to Eliminate Problems


<![CDATA[]]>(MedPage Today) — A novel anti-CD19 CAR T-cell therapy attained a high response rate with minimal neurotoxicity in patients with advanced B-cell lymphoma, according to a preliminary clinical trial. The… Source link